HomeAORT • NYSE
add
Artivion Inc
Previous close
$28.03
Day range
$28.03 - $28.79
Year range
$16.48 - $30.00
Market cap
1.19B USD
Avg Volume
217.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 95.78M | 9.02% |
Operating expense | 53.10M | 3.52% |
Net income | -2.29M | 76.66% |
Net profit margin | -2.39 | 78.58% |
Earnings per share | 0.12 | 500.00% |
EBITDA | 14.02M | 30.59% |
Effective tax rate | -80.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.17M | 5.03% |
Total assets | 803.14M | 3.66% |
Total liabilities | 498.40M | -0.88% |
Total equity | 304.74M | — |
Shares outstanding | 41.92M | — |
Price to book | 3.86 | — |
Return on assets | 2.48% | — |
Return on capital | 2.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.29M | 76.66% |
Cash from operations | 11.46M | 58.39% |
Cash from investing | -10.64M | -414.46% |
Cash from financing | 1.47M | 262.05% |
Net change in cash | 1.15M | -75.48% |
Free cash flow | -5.13M | -271.46% |
About
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Wikipedia
Founded
1984
Headquarters
Website
Employees
1,500
